India’s healthcare sector has experienced remarkable growth in recent years, emerging as a significant contributor to the nation’s economy. This expansion is driven by increased investments, technological advancements, and a growing emphasis on healthcare accessibility.
In 2023, India’s healthcare industry reached a valuation of approximately US$372 billion, reflecting substantial growth fueled by both private and public sector contributions. (Health Economic Times)
The hospital market, a critical component of the healthcare sector, was valued at US$98.98 billion in 2023. Projections indicate a Compound Annual Growth Rate (CAGR) of 8.0% from 2024 to 2032, with expectations to reach US$193.59 billion by 2032. (Health Economic Times)
The telemedicine market in India is anticipated to grow to US$5.4 billion by 2025, driven by increased demand for remote healthcare solutions and technological advancements. (Health Economic Times)
Similarly, the e-health market is projected to reach US$10.6 billion by 2025, underscoring the rapid digital transformation within the healthcare industry. (Health Economic Times)
India’s medical tourism sector was valued at US$7.69 billion in 2024, with expectations to grow to US$14.31 billion by 2029. In 2023, approximately 634,561 foreign tourists visited India for medical treatment, accounting for nearly 6.87% of total international tourists. (Wikipedia)
As of 2024, the healthcare sector is one of India’s largest employers, providing jobs to 7.5 million individuals. Advancements in telemedicine, virtual assistants, and data analytics are expected to create an additional 2.7 to 3.5 million tech-related jobs. (Health Economic Times)
In FY24 (up to February 2024), premiums underwritten by health insurance companies grew to Rs. 2,63,082 crore (approximately US$31.84 billion), with the health segment holding a 33.33% share in total gross written premiums. (Wikipedia)
Public expenditure on healthcare has also seen an upward trend, reaching 2.1% of GDP in FY23, up from 1.6% in FY21, indicating increased government focus on healthcare investment. (Wikipedia)
Between April 2000 and March 2024, the drugs and pharmaceuticals sector attracted US$22.57 billion in FDI. During the same period, hospitals and diagnostic centers received US$10.26 billion, and medical and surgical appliances garnered US$3.28 billion in FDI. (Wikipedia)
In May 2023, Temasek, a Singaporean investment company, invested US$2 billion in Manipal Health Enterprises, highlighting growing interest in India’s healthcare market. (Financial Times)
In September 2023, Nirma, a diversified Indian conglomerate, acquired a 75% stake in Glenmark Life Sciences for US$689 million, marking one of the year’s significant healthcare mergers and acquisitions. (Financial Times)
These developments underscore India’s healthcare sector’s dynamic growth and its increasing appeal to both domestic and international investors. The sector’s expansion is poised to continue, driven by technological innovation, increased investment, and a focus on improving healthcare accessibility and quality.
TERMS OF USE
Thank you for your interest in our Website at https://unlistedintel.com/. Your use of this Website, including the content, materials and information available on or through this Website (together, the “Materials”), is governed by these Terms of Use (these “Terms”). By using this Website, you acknowledge that you have read and agree to these Terms.
NO OFFER, SOLICITATION OR ADVICE
Our site is provided for informational purposes only. It does not constitute to constitute (i) an offer, or solicitation of an offer, to
purchase or sell any security, other assets, or service, (ii) investment, legal, business, or tax advice, or an offer to provide such advice or (iii) a basis for making any investment decision.
The Materials are provided for informational purposes and have been prepared by Oister Global for informational purposes to acquaint existing and prospective underlying funds, entrepreneurs, and other company founders with Oister Global's recent and historical investment activities.
Please note that any investments or portfolio companies referenced in the Materials are illustrative and do not reflect the performance of any Oister Global fund as a whole. There is no obligation for Oister Global to update or alter any forward-looking statements, whether as a result of new information, future events, or otherwise.
PURPOSE LIMITATION AND ACCESS TO YOUR PERSONAL DATA:
We will only collect your personal data in a fair, lawful, and transparent manner. We will keep your personal data accurate and up to date. We will process your personal data in line with your legal rights. We use your name and contact details, such as email, postal address, and contact number to continue communications with you. We may also use your contact information to invite you to events we are hosting or to keep you updated with our news.
USE OF COOKIES OR SIMILAR DEVICES
We use cookies on our website. This helps us to provide you with a better experience when you browse our website and also allows us to make improvements to our site. You may be able to change the preferences on your browser or device to prevent or limit your device’s acceptance of cookies, but this may prevent you from taking advantage of some of our features.
MATERIAL
The material displayed on our site is provided “as is”, without any guarantees, conditions, or warranties as to its accuracy, completeness, or reliability. You should be aware that a significant portion of the Materials includes or consists of information that has been provided by third parties and has not been validated or verified by us. In connection with our investment activities, we often become subject to a variety of confidentiality obligations to funds, investors, portfolio companies, and other third parties. Any statements we make may be affected by those confidentiality obligations, with the result that we may be prohibited from making full disclosures.
MISCELLANEOUS
This Website is operated and controlled by Oister Global in India. We may change the content on our site at any time. If the need arises, we may suspend access to our site, or close it indefinitely. We are under no obligation to update any material on our site.
CONTACT INFORMATION
Any questions, concerns or complaints regarding these Terms should be sent to info@oisterglobal.com